Clinically observed deletions in SARS-CoV-2 Nsp1 affect its stability and ability to inhibit translationVisa övriga samt affilieringar
2022 (Engelska)Ingår i: FEBS Letters, ISSN 0014-5793, E-ISSN 1873-3468, Vol. 596, nr 9, s. 1203-1213Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
Nonstructural protein 1 (Nsp1) of SARS-CoV-2 inhibits host cell translation through an interaction between its C-terminal domain and the 40S ribosome. The N-terminal domain (NTD) of Nsp1 is a target of recurring deletions, some of which are associated with altered COVID-19 disease progression. Here, we characterize the efficiency of translational inhibition by clinically observed Nsp1 deletion variants. We show that a frequent deletion of residues 79–89 severely reduces the ability of Nsp1 to inhibit translation while not abrogating Nsp1 binding to the 40S. Notably, while the SARS-CoV-2 5′ untranslated region enhances translation of mRNA, it does not protect from Nsp1-mediated inhibition. Finally, thermal stability measurements and structure predictions reveal a correlation between stability of the NTD and the efficiency of translation inhibition.
Ort, förlag, år, upplaga, sidor
John Wiley & Sons, 2022. Vol. 596, nr 9, s. 1203-1213
Nyckelord [en]
COVID-19, Nsp1, pathogenicity, ribosome, SARS-CoV-2, virus
Nationell ämneskategori
Medicinsk bioteknologi (med inriktning mot cellbiologi (inklusive stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci) Infektionsmedicin Biokemi Molekylärbiologi
Identifikatorer
URN: urn:nbn:se:umu:diva-194639DOI: 10.1002/1873-3468.14354ISI: 000786558400001PubMedID: 35434785Scopus ID: 2-s2.0-85129091882OAI: oai:DiVA.org:umu-194639DiVA, id: diva2:1658132
Forskningsfinansiär
Cancerfonden, 20 0872 PjKempestiftelserna, JCK-1723.2Knut och Alice Wallenbergs Stiftelse, 2020.0037Vetenskapsrådet, 2017-03783Vetenskapsrådet, 2021-011462022-05-132022-05-132025-02-20Bibliografiskt granskad